BALDUZZI, Sara
 Distribuzione geografica
Continente #
NA - Nord America 6.024
EU - Europa 2.770
AS - Asia 2.563
SA - Sud America 399
Continente sconosciuto - Info sul continente non disponibili 85
AF - Africa 68
OC - Oceania 6
Totale 11.915
Nazione #
US - Stati Uniti d'America 5.883
GB - Regno Unito 919
SG - Singapore 779
CN - Cina 583
IT - Italia 538
HK - Hong Kong 315
BR - Brasile 307
VN - Vietnam 304
SE - Svezia 267
DE - Germania 218
IE - Irlanda 172
BD - Bangladesh 150
FI - Finlandia 123
FR - Francia 108
RU - Federazione Russa 97
UA - Ucraina 90
CA - Canada 79
IN - India 70
KR - Corea 67
TR - Turchia 54
ID - Indonesia 53
NL - Olanda 41
BG - Bulgaria 36
MX - Messico 36
AR - Argentina 34
JP - Giappone 32
BE - Belgio 24
ZA - Sudafrica 23
PL - Polonia 22
PK - Pakistan 18
ES - Italia 16
AT - Austria 15
CL - Cile 15
IQ - Iraq 15
PH - Filippine 14
AE - Emirati Arabi Uniti 12
EC - Ecuador 12
GR - Grecia 12
MY - Malesia 12
LT - Lituania 11
CO - Colombia 9
JO - Giordania 9
MA - Marocco 9
MK - Macedonia 9
NP - Nepal 9
UZ - Uzbekistan 9
CZ - Repubblica Ceca 8
KE - Kenya 8
VE - Venezuela 8
CH - Svizzera 7
CR - Costa Rica 7
IL - Israele 7
TH - Thailandia 7
AU - Australia 6
DK - Danimarca 6
BH - Bahrain 5
CY - Cipro 5
DZ - Algeria 5
IR - Iran 5
OM - Oman 5
PY - Paraguay 5
RO - Romania 5
TN - Tunisia 5
BO - Bolivia 4
MD - Moldavia 4
PE - Perù 4
SA - Arabia Saudita 4
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
JM - Giamaica 3
NO - Norvegia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
BW - Botswana 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
AD - Andorra 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
Totale 11.814
Città #
Southend 661
Ashburn 598
Fairfield 582
Singapore 530
Santa Clara 511
Woodbridge 327
Chandler 311
Hong Kong 307
Houston 235
San Jose 231
Seattle 215
Ann Arbor 192
Wilmington 176
Dublin 171
Beijing 165
Dearborn 162
Cambridge 160
Nyköping 147
Jacksonville 127
Council Bluffs 117
London 106
Chicago 104
New York 104
Hefei 103
Hanoi 93
The Dalles 90
Los Angeles 89
Helsinki 86
Ho Chi Minh City 84
Modena 76
Dallas 61
San Diego 54
Milan 49
Seoul 49
Bologna 40
Jakarta 39
Shanghai 39
Lauterbourg 37
Munich 37
Princeton 35
Moscow 34
Sofia 34
São Paulo 34
Boardman 33
Eugene 32
Redwood City 28
Rome 28
Salt Lake City 28
Buffalo 27
Columbus 26
Phoenix 26
Elk Grove Village 23
Frankfurt am Main 23
Toronto 23
Izmir 22
Brussels 20
Tampa 20
Bremen 19
Orem 19
Turin 19
Warsaw 19
Fremont 18
Montreal 18
Tokyo 18
San Francisco 17
Mexico City 16
Atlanta 14
Sterling 14
Dong Ket 13
Norwalk 13
Brooklyn 12
Haiphong 11
Ottawa 10
Paris 10
Redondo Beach 10
Reggio Emilia 10
Chennai 9
Hillsboro 9
Seongnam 9
Turku 9
Cleveland 8
Da Nang 8
Istanbul 8
North Bergen 8
Rio de Janeiro 8
Tilburg 8
Amman 7
Amsterdam 7
Biên Hòa 7
Brasília 7
Buenos Aires 7
Johannesburg 7
Lappeenranta 7
Louisville 7
Nagoya 7
Nanjing 7
Stockholm 7
Tashkent 7
Changchun 6
Denver 6
Totale 8.221
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 491
Non-steroid agents for idiopathic pulmonary fibrosis 474
Indicators of Complex Care During the Consultation-Liaison Psychiatry Activity at the Transplant Center of the Policlinico Hospital, Modena 450
The impact of shift work on the psychological and physical health of nurses in a general hospital: a comparison between rotating night shifts and day shifts 416
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 414
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 397
Short-term and long-term effects of tibolone in postmenopausal women 388
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 385
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 380
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER 368
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 363
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 356
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 355
3* Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer 339
"the More the Better" Paradox of Antenatal Ultrasound Examinations in Low-Risk Pregnancy 339
Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience. 317
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 300
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV 300
Trastuzumab containing regimens for early breast cancer. 298
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 297
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 293
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 290
Systematic review of maternal voice interventions demonstrates increased stability in preterm infants 288
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 288
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 286
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 279
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 272
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 271
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 270
Short and long term effects of tibolone in postmenopausal women 255
Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study 247
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 244
Trastuzumab-containing regimens for metastatic breast cancer 235
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 207
Erlotinib for advanced pancreatic cancer 180
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 179
Outpatient parents' views on shared-decision-making at an Italian children's hospital 161
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 150
Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial. 56
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical Trial. 37
Totale 11.915
Categoria #
all - tutte 42.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.878


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022819 46 47 97 43 27 49 33 57 91 82 157 90
2022/20231.033 95 123 72 92 94 100 26 94 261 13 18 45
2023/2024622 21 28 46 53 103 59 80 63 23 39 43 64
2024/20251.858 57 25 38 110 371 321 148 117 170 76 179 246
2025/20263.832 235 101 260 377 654 244 518 202 369 390 308 174
2026/2027153 153 0 0 0 0 0 0 0 0 0 0 0
Totale 11.915